Custom Dynamic Orthoses to Reduce Articular Contact Stress (PRMRP FPA CT)

December 7, 2023 updated by: Jason Wilken, University of Iowa
The proposed study evaluates the effect of carbon fiber brace design on forces across the ankle. Research suggests that ankle arthritis develops following ankle fracture due, in part, to elevated forces on the cartilage. It is expected that carbon fiber braces can reduce forces in the ankle joint thereby reducing the risk of developing arthritis following injury. In this study, carbon fiber braces will be tested to determine how they influence the forces acting on the ankle cartilage. The proposed study will provide evidence that can be used by clinicians and researchers to design carbon fiber braces to effectively reduce forces on ankle cartilage.

Study Overview

Detailed Description

The primary purpose of this line of research is to investigate the effects of carbon fiber custom dynamic orthosis (CDO) use on forces and contact stress at the ankle, with the goal of reducing the development of post traumatic osteoarthritis (PTOA). Research suggests that PTO develops, in part, due to increased ankle contact stress following fracture. It is expected that reducing articular contact stress has the potential to delay or prevent PTOA development. CDOs have been shown to significantly improve function after extremity injury, and show promise for offloading the injured ankle joint after severe lower extremity injuries. Therefore, the proposed effort is designed to evaluate CDOs effects on forces and articular contact stress at the ankle.

Adult participants who have sustained a traumatic ankle fracture of the tibial pilon will be evaluated while wearing two CDOs, with a primary dependent measure of ankle joint contact stress. Following consent and enrollment weight bearing computerized tomography (CT) images will be collected and used to determine the geometry of the joint, and the articular contact stress using discrete element analysis.

Participants will be cast and fit for two CDOs. Participants will be blinded to the design variation of each device and will only know them as CDO-A or CDO-B. Testing will be completed under 3 conditions: No-CDO, CDO-A, CDO-B, with each bracing condition (A/B) representing a different CDO. Physical performance measures will incorporate tests of agility, speed, and lower limb power to ensure that the CDOs do not negatively affect physical function. Questionnaires will be used to evaluate participants' current and desired activity level, pain with and without using a CDO, satisfaction with the study CDOs, perception of comfort and smoothness between CDOs, and preference between CDOs. Semi-structured interviews will be completed to fully capture the participant's perspective with each study CDO. Lower limb forces and motion will be assessed using a computerized motion capture system and force plates embedded in the floor. Forces between the foot and CDO footplate will be measured using force sensing insoles, and muscle activity data will be collected using wireless surface electromyography sensors. Each CDO will be mechanically tested, and participant demographic and anthropometric data will be recorded.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Iowa
      • Iowa City, Iowa, United States, 52241
        • University of Iowa
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Molly Pacha, MS, ATC, LAT
        • Sub-Investigator:
          • Michael C Willey, MD
        • Sub-Investigator:
          • Jeff Palmer, CPO, LPO
        • Sub-Investigator:
          • Donald D Anderson, PhD
        • Principal Investigator:
          • Jason M Wilken, PT, PhD
        • Sub-Investigator:
          • Cesar De Cesar Netto, MD
        • Sub-Investigator:
          • Matthew Karam, MD
        • Sub-Investigator:
          • J Lawrence Marsh, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Between the ages of 18 and 65
  • Sustained unilateral fracture of the tibial pilon
  • The fracture has completely healed
  • Ability to walk 50 feet without use of an assistive device (cane, crutch, etc.)
  • Ability to walk at a slow to moderate pace
  • Shoe size between women's 8 and 13.5 or men's 6.5 and 12
  • Ability to read and write in English and provide written informed consent
  • Individuals with elevated contact stress according to model generated using standing CT images (will be answered after completing visit one)

Exclusion Criteria:

  • Pain > 6/10 while walking
  • Increase in pain during testing of 3/10 or greater
  • Neurologic, musculoskeletal (including bilateral fractures) or other condition limiting function of the contralateral extremity
  • Medical or psychological condition that would preclude functional testing (ex. moderate or severe brain injury, stroke, heart disease)
  • Wounds to the calf that would prevent CDO fitting
  • Fractures secondary to neuropathy or severe osteopenia
  • Classification as non-ambulatory
  • Previous fractures near the tibial pilon on the involved limb
  • Surgery on involved limb anticipated in the next 6 months
  • Requirement of a knee stabilizing device (i.e. KAFO, KO…) to perform daily activities
  • Visual or hearing impairments that limit walking ability or limit the ability to comply with instructions given during testing
  • BMI greater than 40
  • Pregnancy- Per participant self-report. Due to the expected small number of pregnant individuals and resulting inability to account for its effect on resulting outcomes, participants will be withdrawn from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: NoCDO
Participants will be evaluated without a CDO
Experimental: CDO-A
The first study CDO will be designated CDO-A
The carbon fiber custom dynamic orthosis will consist of a semi-rigid foot plate, a posterior carbon fiber strut, and a proximal cuff below the knee.
Other Names:
  • Ankle Foot Orthosis (AFO)
Experimental: CDO-B
The second study CDO will be designated CDO-B
The carbon fiber custom dynamic orthosis will consist of a semi-rigid foot plate, a posterior carbon fiber strut, and a proximal cuff below the knee.
Other Names:
  • Ankle Foot Orthosis (AFO)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numerical Pain Rating Scale
Time Frame: Baseline
Pain will be assessed using a standard 11-point numerical pain rating scale, in which 0 = no pain and 10 = worst pain imaginable.
Baseline
Joint Contact Stress Exposure (Model estimated)
Time Frame: Baseline
Joint contact stress exposure (MPA-s/gait cycle) will be estimated using a participant specific musculoskeletal model.
Baseline
Participant Device Preference
Time Frame: Baseline
The participant will rank order their preference for their standard of care device (if applicable), NoCDO, CDO-A, CDO-B on a questionnaire.
Baseline
Peak Plantar Force (total foot)
Time Frame: Baseline
Plantar forces (N) will be measured across the forefoot (100% of sensor) as participants walk without a CDO and with each CDO.
Baseline
Plantar Force Impulse (total foot)
Time Frame: Baseline
Plantar force impulse (Ns) across the forefoot (100% of sensor) will be calculated using the integral of the force over the stance phase as participants walk without a CDO and with each CDO.
Baseline
Peak Plantar Force (forefoot)
Time Frame: Baseline
Plantar forces (N) will be measured across the forefoot (distal 40% of sensor) as participants walk without a CDO and with each CDO.
Baseline
Plantar Force Impulse (forefoot)
Time Frame: Baseline
Plantar force impulse (Ns) across the forefoot (distal 40% of sensor) will be calculated using the integral of the force over the stance phase as participants walk without a CDO and with each CDO.
Baseline
Peak Plantar Force (midfoot)
Time Frame: Baseline
Plantar forces (N) will be measured across the forefoot (middle 30% of sensor) as participants walk without a CDO and with each CDO.
Baseline
Plantar Force Impulse (midfoot)
Time Frame: Baseline
Plantar force impulse (Ns) across the forefoot (middle 30% of sensor) will be calculated using the integral of the force over the stance phase as participants walk without a CDO and with each CDO.
Baseline
Peak Plantar Force (hindfoot)
Time Frame: Baseline
Plantar forces (N) will be measured across the forefoot (proximal 30% of sensor) as participants walk without a CDO and with each CDO.
Baseline
Plantar Force Impulse (hindfoot)
Time Frame: Baseline
Plantar force impulse (Ns) across the forefoot (proximal 30% of sensor) will be calculated using the integral of the force over the stance phase as participants walk without a CDO and with each CDO.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Four Square Step Test (4SST)
Time Frame: Baseline
The 4SST (s) is a standardized timed test of balance and agility.
Baseline
Sit to Stand 5 Times (STS5)
Time Frame: Baseline
STS5 (s) is a well-established timed measure of lower limb muscle strength and power. Participants are instructed to stand up and sit down 5 times as fast as possible.
Baseline
Ankle Range of Motion
Time Frame: Baseline
Ankle range of motion (degrees) during gait.
Baseline
Peak Ankle Moment
Time Frame: Baseline
Peak ankle moment (Nm/kg) during gait.
Baseline
Peak Ankle Power
Time Frame: Baseline
Peak ankle power (W/kg) during gait.
Baseline
The Orthotics Prosthetics Users' Survey (OPUS)
Time Frame: Baseline
Satisfaction with device will be assessed using the Orthotics Prosthetics Users' Survey Satisfaction With Device Score (11-55). Lower scores indicate a better outcome.
Baseline
Modified Socket Comfort Score (Comfort)
Time Frame: Baseline
Comfort scores range from 0 = most uncomfortable to 10 = most comfortable.
Baseline
Modified Socket Comfort Score (Smoothness)
Time Frame: Baseline
Smoothness scores range from 0 = least smooth to 10 = most smooth.
Baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Center of pressure velocity timing
Time Frame: Baseline
Timing of peak center of pressure velocity (percent stance) during gait.
Baseline
Center of pressure velocity magnitude
Time Frame: Baseline
Magnitude of peak center of pressure velocity (m/s) during gait.
Baseline
Soleus Muscle Activity (Electromyography)
Time Frame: Baseline
Electromyography (EMG, % Maximum) of the soleus during gait.
Baseline
Tibialis Anterior Muscle Activity (Electromyography)
Time Frame: Baseline
Electromyography (EMG, % Maximum) of theTibialis Anterior during gait.
Baseline
Medial Gastrocnemius Muscle Activity (Electromyography)
Time Frame: Baseline
Electromyography (EMG, % Maximum) of the Medial Gastrocnemius during gait.
Baseline
Rectus Femoris Muscle Activity (Electromyography)
Time Frame: Baseline
Electromyography (EMG, % Maximum) of the Rectus Femoris during gait.
Baseline
Vastus Medialis Muscle Activity (Electromyography)
Time Frame: Baseline
Electromyography (EMG, % Maximum) of the Vastus Medialis during gait.
Baseline
Semi-Structured Interview
Time Frame: Baseline
Semi-structured interviews will also be used to fully capture the patients' perspectives, experience, and opinions associated with the device options they experienced as part of the study.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jason M Wilken, PT, PhD, University of Iowa

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2024

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

January 12, 2022

First Submitted That Met QC Criteria

January 12, 2022

First Posted (Actual)

January 26, 2022

Study Record Updates

Last Update Posted (Estimated)

December 14, 2023

Last Update Submitted That Met QC Criteria

December 7, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-traumatic Osteoarthritis

Clinical Trials on Carbon Fiber Custom Dynamic Orthosis (CDO)

3
Subscribe